Baclofen for alcohol withdrawal in liver disease
Treatments studied
Part of Digestive system clinical trials.
This trial tests if baclofen, a medicine for alcohol dependence, is safe and works for people with chronic liver disease who are actively drinking. It may help you stop drinking alcohol safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic liver disease at any stage.
- You are actively drinking alcohol.
- You are going to use baclofen to treat your alcohol dependence.
- You do not have a severe mental health condition that requires other psychiatric medications.
- You do not have kidney failure or severe kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an optimized treatment plan can improve remission in people with liver cirrhosis caused by alcohol. It aims to help patients achieve better health outcomes.
This study is looking at liver health in people staying in a detox unit for alcohol use disorder. Researchers want to see how common liver problems are in this group. Participating involves extra tests like blood work, an ultrasound, and a special liver scan (FibroScan).
This trial tests if baclofen can help people with both anxiety and alcohol use disorder. It is an open-label study, meaning everyone knows they are taking the medication. Researchers want to see if it supports people in staying alcohol-free.
This trial tests whether taking fiber as a dietary supplement can help people manage alcohol withdrawal symptoms during a 7-day hospital stay. It may offer a simple, non-drug way to support recovery.
This trial tests whether baclofen can make it easier to reduce (taper) benzodiazepines in people who have been dependent for a long time and previously had trouble stopping. If you can safely take part, it may help improve the tapering process and reduce withdrawal problems.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Hear when a new Alcoholic Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.